The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Genetic control of the circulating concentration of transforming growth factor type beta1
Abstract
The concentration of transforming growth factor beta (TGF-beta) in plasma has been correlated with the development of several diseases, including atherosclerosis and certain forms of cancer. However, the mechanisms that control the concentration of TGF-beta in plasma are poorly understood. In a study of 170 pairs of female twins (average age 57.7 years) we show that the concentration of active plus acid-activatable latent TGF-beta1 [(a+l) TGF-beta therefore is predominantly under genetic control (heritability estimate 0.54). Single strand conformation polymorphism (SSCP) mapping of the TGF-beta1 gene promoter has identified two single base substitution polymorphisms. The two polymorphisms (G-->A at position -800 bp and C-->T at position -509 bp) are in linkage disequilibrium (correlation coefficient Delta = 0.215, P < 0.01). The C-509T polymorphism is significantly associated with the plasma concentration of (a+l) TGF-beta1, explaining 8.2% of the additive genetic variance of (a+l) TGF-beta1 concentration. It is therefore possible that predisposition to atherosclerosis, bone diseases or various forms of cancer may be correlated with the presence of particular alleles at the TGFB1 locus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Longitudinal Data Analysis for Discrete and Continuous Outcomes
Zeger, S. L., & Liang, K.-Y. (1986) · Biometrics · doi:10.2307/2531248 · Cited by 7,764
Methodology for Genetic Studies of Twins and Families
Neale, M. C., & Cardon, L. R. (1992) · doi:10.1007/978-94-015-8018-2 · Cited by 4,005 · cited 1×
“Model fitting has major advantages over the classic twin methodology (32, 33 ), allowing more extensive separation of the observed phenotypic variance into additive ( VA) and dominant (VD) genetic components as well as shared ( VC) and unique (VE) environmental components.”
BackgroundInactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite Instability
Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., et al. (1995) · Science · doi:10.1126/science.7761852 · Cited by 2,270
McAllister, K. A., Grogg, K. M., Johnson, D. W., Gallione, C. J., Baldwin, M. A., Jackson, C. E., Helmbold, E. A., Markel, D. S., McKinnon, W. C., Murrel, J., et al. (1994) · Nature Genetics · doi:10.1038/ng1294-345 · Cited by 1,482
Extensions to pedigree analysis III. Variance components by the scoring method
LANGE, K., WESTLAKE, J., & SPENCE, M. A. (1976) · Annals of Human Genetics · doi:10.1111/j.1469-1809.1976.tb00156.x · Cited by 418
Torre-Amione, G., Beauchamp, R. D., Koeppen, H., Park, B. H., Schreiber, H., Moses, H. L., & Rowley, D. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1486 · Cited by 403
Characterization of the Promoter Region of the Human Transforming Growth Factor-β1 Gene
Kim, S. J., Glick, A., Sporn, M. B., & Roberts, A. B. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31272-3 · Cited by 393
Grainger, D. J., Kemp, P. R., Metcalfe, J. C., Liu, A. C., Lawn, R. M., Williams, N. R., Grace, A. A., Schofield, P. M., & Chauhan, A. (1995) · Nature Medicine · doi:10.1038/nm0195-74 · Cited by 378
Self-citationCambien, F., Ricard, S., Troesch, A., Mallet, C., Générénaz, L., Evans, A., Arveiler, D., Luc, G., Ruidavets, J.-B., & Poirier, O. (1996) · Hypertension · doi:10.1161/01.hyp.28.5.881 · Cited by 363
Arteaga, C. L., Hurd, S. D., Winnier, A. R., Johnson, M. D., Fendly, B. M., & Forbes, J. T. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116871 · Cited by 359
Activation of transforming growth factor-β is inhibited in transgenic apolipoprotein(a) mice
Grainger, D. J., Kemp, P. R., Liu, A. C., Lawn, R. M., & Metcalfe, J. C. (1994) · Nature · doi:10.1038/370460a0 · Cited by 352
Self-citationExtensions to Pedigree Analysis
Lange, K., & Elston, R. C. (1975) · Human Heredity · doi:10.1159/000152714 · Cited by 326
Anscher, M. S., Peters, W. P., Reisenbichler, H., Petros, W. P., & Jirtle, R. L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306033282203 · Cited by 316
Kim, S.-J., Wagner, S., Liu, F., O'Reilly, M. A., Robbins, P. D., & Green, M. R. (1992) · Nature · doi:10.1038/358331a0 · Cited by 247
Release and activation of platelet latent TGF–β in blood clots during dissolution with plasmin
Grainger, D. J., Wakefield, L., Bethell, H. W., Farndale, R. W., & Metcalfe, J. C. (1995) · Nature Medicine · doi:10.1038/nm0995-932 · Cited by 225
Self-citationLangdahl, B. L., Knudsen, J. Y., Jensen, H. K., Gregersen, N., & Eriksen, E. F. (1997) · Bone · doi:10.1016/s8756-3282(96)00363-8 · Cited by 216
Spector, T. D., Keen, R. W., Arden, N. K., Morrison, N. A., Major, P. J., Nguyen, T. V., Kelly, P. J., Baker, J. R., Sambrook, P. N., Lanchbury, J. S., et al. (1995) · BMJ · doi:10.1136/bmj.310.6991.1357 · Cited by 184
Elevated plasma levels of TGF-β1 in patients with invasive prostate cancer
Ivanovic, V., Melman, A., Davis-Joseph, B., Valcic, M., & Geliebter, J. (1995) · Nature Medicine · doi:10.1038/nm0495-282 · Cited by 176
Transforming growth factor-beta 1 null mice. An animal model for inflammatory disorders.
Kulkarni, A. B., Ward, J. M., Yaswen, L. R., Mackall, C. L., Bauer, S. R., Huh, C.-G., Gress, R. E., & Karlsson, S. (1995) · PubMed · Cited by 166
Mechanisms of transactivation by retinoic acid receptors
Stunnenberg, H. G. (1993) · BioEssays · doi:10.1002/bies.950150504 · Cited by 155
Grainger, D. J., Witchell, C., & Metcalfe, J. C. (1995) · Nature Medicine · doi:10.1038/nm1095-1067 · Cited by 136
Self-citationTamoxifen: Teaching an old drug new tricks?
Grainger, D. J., & Metcalfe, J. C. (1996) · Nature Medicine · doi:10.1038/nm0496-381 · Cited by 125
Self-citationTransforming growth factor-β dynamically regulates vascular smooth muscle differentiation in vivo
Grainger, D. J., Metcalfe, J. C., Grace, A. A., & Mosedale, D. E. (1998) · Journal of Cell Science · doi:10.1242/jcs.111.19.2977 · Cited by 103
Self-citationDanielpour, D. (1996) · Journal of Cellular Physiology · Cited by 99
Reckless, J., Metcalfe, J. C., & Grainger, D. J. (1997) · Circulation · doi:10.1161/01.cir.95.6.1542 · Cited by 92
Self-citationActive and acid-activatable TGF-β in human sera, platelets and plasma
Grainger, D. J., Mosedale, D. E., Metcalfe, J. C., Weissberg, P. L., & Kemp, P. R. (1995) · Clinica Chimica Acta · doi:10.1016/0009-8981(94)05995-4 · Cited by 91
Self-citationCui, W., Kemp, C. J., Duffie, E., Balmain, A., & Akhurst, R. J. (1994) · PubMed · Cited by 61
Feedback Mechanism of Focal Vascular Lesion Formation in Transgenic Apolipoprotein(a) Mice
Lawn, R. M., Pearle, A. D., Kunz, L. L., Rubin, E. M., Reckless, J., Metcalfe, J. C., & Grainger, D. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31367 · Cited by 59
Self-citation
Cited by
Role of Transforming Growth Factor β in Human Disease
Blobe, G. C., Schiemann, W. P., & Lodish, H. F. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005043421807 · Cited by 2,427
Carnitine—metabolism and functions
Bremer, J. (1983) · Physiological Reviews · doi:10.1152/physrev.1983.63.4.1420 · Cited by 1,666
Roles of TGF-beta in hepatic fibrosis
Gressner, A. M. (2002) · Frontiers in Bioscience · doi:10.2741/a812 · Cited by 783
Transforming Growth Factor-β1 to the Bone
Janssens, K., ten Dijke, P., Janssens, S., & Van Hul, W. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0001 · Cited by 710
Protection from obesity and diabetes by blockade of TGF-β/smad3 signaling
Yadav, H., Quijano, C., Kamaraju, A. K., Gavrilova, O., Malek, R., Chen, W., Zerfas, P., Zhigang, D., Wright, E. C., Stuelten, C., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.04.013 · Cited by 709
Metadata
- Authors
- Grainger, D.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-01-01
- Volume
- 8
- Issue
- 1
- Pages
- 93-97
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2126352920
- Cited by
- 755
- References
- 28
- FWCI
- 10.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.